Treatment with the pan-PI3K inhibitor BKM120 in mice bearing breast tumors was found to increase the tumor infiltration of NK cells, B cells, and CD4 + and CD8 + T cells, favoring antitumor immunity [49]. The gene discussed is CD4; the disease is neoplasm.